Viatris Net Worth 2012-2025 | VTRS

Interactive chart of historical net worth (market cap) for Viatris (VTRS) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Viatris net worth as of January 13, 2026 is $14.6B.
Sector Industry Market Cap Revenue
Medical Medical Services $14.604B $14.739B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $168.818B 31.00
HCA Healthcare (HCA) United States $108.237B 17.92
CVS Health (CVS) United States $102.012B 11.73
Elevance Health (ELV) United States $83.333B 12.22
Cencora (COR) United States $66.377B 21.40
Natera (NTRA) United States $32.568B 0.00
DiDi Global (DIDIY) China $23.956B 22.13
Labcorp Holdings (LH) United States $20.757B 15.83
Medpace Holdings (MEDP) United States $16.879B 41.90
EUROFINS SCIENT (ERFSF) Luxembourg $16.455B 0.00
BioMerieux (BMXMF) France $15.505B 0.00
Solventum (SOLV) United States $14.863B 14.43
ICON (ICLR) Ireland $14.548B 14.44
Revvity (RVTY) United States $11.779B 21.69
CochLear (CHEOY) Australia $11.666B 0.00
Charles River Laboratories (CRL) United States $10.769B 20.74
Avantor (AVTR) United States $8.373B 12.79
Sonic Healthcare (SKHHY) Australia $7.695B 0.00
HealthEquity (HQY) United States $7.224B 27.02
Caris Life Sciences,�Inc (CAI) United States $7.223B 0.00
BrightSpring Health Services (BTSG) United States $7.036B 41.95
PACS (PACS) United States $6.501B 39.53
Bausch + Lomb (BLCO) Canada $6.199B 40.70
Sotera Health (SHC) United States $5.395B 26.01
Alignment Healthcare (ALHC) United States $4.258B 0.00
Amplifon S.p.A (AMFPF) Italy $3.719B 21.70
GeneDx Holdings (WGS) United States $3.447B 60.53
Concentras Parent (CON) United States $2.642B 16.49
Progyny (PGNY) United States $2.450B 48.17
Organon (OGN) United States $2.111B 2.22
Surgery Partners (SGRY) United States $2.106B 27.13
Pediatrix Medical (MD) United States $1.946B 11.62
Establishment Labs Holdings (ESTA) United States $1.940B 0.00
Teladoc Health (TDOC) United States $1.287B 0.00
Nutex Health (NUTX) United States $1.278B 9.77
Ardent Health (ARDT) United States $1.269B 4.14
CareDx (CDNA) United States $1.058B 17.29
GoodRx Holdings (GDRX) United States $0.978B 16.00
Omada Health (OMDA) United States $0.933B 0.00
Embecta (EMBC) United States $0.761B 4.33
InnovAge Holding (INNV) United States $0.754B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.672B 0.00
Sonida Senior Living (SNDA) United States $0.602B 0.00
CryoPort (CYRX) United States $0.533B 0.00
Enhabit (EHAB) United States $0.516B 23.16
Strata Critical Medical (SRTA) United States $0.500B 0.00
Charming Medical (MCTA) Hong Kong, SAR China $0.497B 0.00
SBC Medicals (SBC) United States $0.459B 8.43
Agilon Health (AGL) United States $0.409B 0.00
Oncology Institute (TOI) United States $0.379B 0.00
QDM (QDMI) Hong Kong, SAR China $0.358B 75.29
Auna S.A (AUNA) Luxembourg $0.355B 5.70
Shoulder Innovations (SI) United States $0.292B 0.00
So-Young (SY) China $0.278B 0.00
KindlyMD (NAKA) United States $0.203B 0.00
LifeMD (LFMD) United States $0.202B 0.00
Beauty Health (SKIN) United States $0.193B 0.00
Ascend Wellness Holdings (AAWH) United States $0.144B 0.00
Sera Prognostics (SERA) United States $0.139B 0.00
DocGo (DCGO) United States $0.088B 0.00
Biodesix (BDSX) United States $0.064B 0.00
Park Dental Partners (PARK) United States $0.062B 0.00
IceCure Medical (ICCM) Israel $0.046B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.045B 0.00
Pomdoctor - (POM) China $0.032B 0.00
Synergy CHC (SNYR) United States $0.020B 6.24
Intelligent Bio Solutions (INBS) United States $0.019B 0.00
OSR Holdings (OSRH) United States $0.018B 0.00
Basel Medical Group (BMGL) Singapore $0.012B 0.00
Co-Diagnostics (CODX) United States $0.012B 0.00
Lifeward (LFWD) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Pheton Holdings (PTHL) China $0.003B 0.00
XWELL (XWEL) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.000B 0.00
Cano Health (CANOQ) United States $0.000B 0.00